Webinar: PrEP Beyond Pills – New Technologies in Biomedical HIV Prevention
Facilitated by Christopher B. Hurt, MD
Associate Professor of Medicine
Director, North Carolina HIV Training & Education Center
Site PI, Ryan White HIV/AIDS Program Part D, UNC ID Clinic
Co-Leader, UNC CFAR Collaborative HIV Epidemiology & Prevention Scientific Working Group
Institute for Global Health & Infectious Diseases
University of North Carolina at Chapel Hill
School of Medicine
September 23, 2020
Other Trainings
- Webinar: HIV Pre-Exposure Prophylaxis 2023
- Webinar: Implementation of Evidence-Based Interventions in HIV Prevention and Care: From Malawi to North Carolina
- Archived Session: HIV Prevention for Women in the South
- Webinar: Update on PrEP: Focus on the Medications
- Staying PrEPared: An Update on Injectable Pre-Exposure Prophylaxis
Objectives
- List three ways in which pre-exposure prophylaxis may be delivered in the future.
- Describe the results of HPTN 083 and what this means for PrEPin the near term.
- Identify the agent currently under investigation as implantable PrEP.
- Explain how broadly neutralizing antibodies work to prevent HIV infections.
Presentation
Slides
Facilitated by Christopher B. Hurt, MD
Associate Professor of Medicine
Director, North Carolina HIV Training & Education Center
Site PI, Ryan White HIV/AIDS Program Part D, UNC ID Clinic
Co-Leader, UNC CFAR Collaborative HIV Epidemiology & Prevention Scientific Working Group
Institute for Global Health & Infectious Diseases
University of North Carolina at Chapel Hill
School of Medicine
September 23, 2020
Objectives
- List three ways in which pre-exposure prophylaxis may be delivered in the future.
- Describe the results of HPTN 083 and what this means for PrEPin the near term.
- Identify the agent currently under investigation as implantable PrEP.
- Explain how broadly neutralizing antibodies work to prevent HIV infections.
Presentation
Slides
Other Trainings
- Webinar: HIV Pre-Exposure Prophylaxis 2023
- Webinar: Implementation of Evidence-Based Interventions in HIV Prevention and Care: From Malawi to North Carolina
- Archived Session: HIV Prevention for Women in the South
- Webinar: Update on PrEP: Focus on the Medications
- Staying PrEPared: An Update on Injectable Pre-Exposure Prophylaxis
Facilitated by Christopher B. Hurt, MD
Associate Professor of Medicine
Director, North Carolina HIV Training & Education Center
Site PI, Ryan White HIV/AIDS Program Part D, UNC ID Clinic
Co-Leader, UNC CFAR Collaborative HIV Epidemiology & Prevention Scientific Working Group
Institute for Global Health & Infectious Diseases
University of North Carolina at Chapel Hill
School of Medicine
September 23, 2020
Objectives
- List three ways in which pre-exposure prophylaxis may be delivered in the future.
- Describe the results of HPTN 083 and what this means for PrEPin the near term.
- Identify the agent currently under investigation as implantable PrEP.
- Explain how broadly neutralizing antibodies work to prevent HIV infections.
Presentation
Slides
Other Trainings
- Webinar: HIV Pre-Exposure Prophylaxis 2023
- Webinar: Implementation of Evidence-Based Interventions in HIV Prevention and Care: From Malawi to North Carolina
- Archived Session: HIV Prevention for Women in the South
- Webinar: Update on PrEP: Focus on the Medications
- Staying PrEPared: An Update on Injectable Pre-Exposure Prophylaxis
